
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
Cancer immunotherapies require different standards for evaluating their safety and effectiveness. Understanding these standards-and the other major challenges of immuno-oncology studies-is critical to drug development success.
Published: February 13th 2025 | Updated: March 4th 2025
Published: February 19th 2025 | Updated: February 26th 2025
Published: March 24th 2023 | Updated:
Published: April 28th 2021 | Updated:
Published: July 26th 2024 | Updated:
Published: January 31st 2024 | Updated: